This is fantastic news for IDH-mutant glioma patients !!
We are not used to seeing curves like this as brain tumor researchers – I can’t wait until the day we see a curve like this for high grade and IDH wild type glioblastoma Inspiring results, now time to get back to work.
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma, The New England Journal of Medicine, 2023
Source: Tyler E Miller/Twitter
